Ocular Therapeutix OCUL reported its Q4 earnings results on Monday, March 11, 2024 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Ocular Therapeutix missed estimated earnings by -17.0%, reporting an EPS of $-0.35 versus an estimate of $-0.3.
Revenue was up $726 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 13.0% drop in the share price the next day.
Here's a look at Ocular Therapeutix's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.29 | -0.29 | -0.26 | -0.25 |
| EPS Actual | -0.25 | -0.26 | -0.39 | -0.24 |
| Revenue Estimate | 15.25M | 14.64M | 14.10M | 13.53M |
| Revenue Actual | 15.08M | 15.19M | 13.37M | 14.08M |
To track all earnings releases for Ocular Therapeutix visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
